Don't miss

Replay


LATEST SHOWS

BUSINESS DAILY

French government, employers and unions begin final discussions on labour reforms

Read more

IN THE PAPERS

'Here are six costly failures from America’s longest war. No. 1: cashmere goats'

Read more

IN THE PAPERS

Charter of transparency…but no official ‘first lady’ title for Brigitte Macron

Read more

EYE ON AFRICA

Nigeria's Buhari slams divisions after a 3-month absence

Read more

THE DEBATE

What's next for the "Islamic State Group"?

Read more

ENCORE!

Opera singers Thomas Hampson & Luca Pisaroni return to Paris

Read more

FOCUS

Hunger has forced many Nigerian refugees in northern Cameroon to return to dangerous Boko Haram territory.

Read more

BUSINESS DAILY

US investigating China's intellectual property policy

Read more

IN THE PAPERS

Bonnie Tyler to sing 'Total Eclipse of the Heart' during total solar eclipse

Read more

Belgian Tom Boonen fails drugs test for cocaine

Video by FRANCE 24

Latest update : 2009-05-09

Tom Boonen of team Quick Step has tested positive for cocaine The 28-year-old Belgian, who clinched the Paris-Roubaix race for the third time last month, also tested positive for the same substance last year.

REUTERS - Belgian rider Tom Boonen has failed an out-of-competition test for cocaine, his Quick Step team said on Saturday.

"The test, which was positive for cocaine, was carried out by the Flemish authorities," team spokesman Alessandro Tegner said.

"It was about two weeks ago. There is a team meeting to discuss the situation."

Boonen, who won the Paris-Roubaix classic for the third time last month and is among the top one-day race riders in the world, previously failed a test for cocaine last year.

Jan Poels, a public prosecutor in the northeast Belgian town of Turnhout, said a search had been carried out at Boonen's home at the end of April in connection with a drugs investigation.

He declined to say whether drugs were found or whether the investigation concerned any particular substance.
 

Date created : 2009-05-09

COMMENT(S)